semaglutide and optic neuritis Wegovy may raise risk of ischemic neuropathy ποΈ The obesity drug semaglutide, marketed as Wegovy, was associated with a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic nonarteritic anterior ischemic optic neuropathy
Pay in 4 interest-free payments of $5.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27




















